4//SEC Filing
Aharon Gil 4
Accession 0001811824-24-000004
CIK 0000872912other
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 3:47 PM ET
Size
8.7 KB
Accession
0001811824-24-000004
Insider Transaction Report
Form 4
Aharon Gil
Director
Transactions
- Exercise/Conversion
Tranche B warrants to purchase F-4 Preferred Stock
2024-10-30$1000.00/sh+500$500,000→ 0 total(indirect: By Rosalind Advisors, Inc., the advisor to the Rosalind Funds)Exercise: $1000.00From: 2023-03-29→ F-4 PREFERRED STOCK (500 underlying) - Expiration (Short)
8% CONVERTIBLE NOTE
2024-10-30+0→ 0 total(indirect: By Rosalind Advisors, Inc., the advisor to the Rosalind Funds)Exercise: $0.00→ CASH
Footnotes (5)
- [F1]Immediately exercisable
- [F2]The Tranche B Warrants expire the earlier of (i) twenty-one (21) days following the date of the Issuer's public announcement of record at least $10,000,000 in quarterly U.S. revenue from the commercialization of HEPZATO and (ii) March 31, 2026. The Issuer announced on October 17, 2024 that it had recorded at least $10,000,000 in quarterly U.S. revenue from the commercialization of HEPZATO and therefore such Tranche B Warrants expire on November 7, 2024.
- [F3]Reporting Persons disclaims beneficial ownership over the shares except to the extent of his or its respective pecuniary interest therein
- [F4]N/A
- [F5]Delcath repaid the DELCATH SYSTEM - 8% CONVERTIBLE NOTE in full with cash of $1,423,333.
Documents
Issuer
DELCATH SYSTEMS, INC.
CIK 0000872912
Entity typeother
Related Parties
1- filerCIK 0001811824
Filing Metadata
- Form type
- 4
- Filed
- Oct 31, 8:00 PM ET
- Accepted
- Nov 1, 3:47 PM ET
- Size
- 8.7 KB